Brief: Vyant Bio Reports First Quarter 2022 Results And Provides Strategic And Business Highlights
May 16 (Reuters) - Vyant Bio Inc VYNT.O :
* VYANT BIO REPORTS FIRST QUARTER 2022 RESULTS AND PROVIDES
STRATEGIC AND BUSINESS HIGHLIGHTS
* VYANT BIO INC - CASH POSITION AS OF MARCH 31, 2022 WAS
$16.4
MILLION
* VYANT BIO INC - QTRLY NET LOSS PER SHARE $0.32
Source text for Eikon: ID:nGNXr9c8p
Further company coverage: VYNT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyant Bio
See all newsBrief: Vyant Bio Provides Update On Winddown Activities
Brief: Vyant Bio Announces Stockholder Approval Of Plan Of Dissolution
Brief: Vyant Bio Files Form 15 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Filing Of Form 25 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Voluntary Nasdaq Delisting, SEC Deregistration